Does the media refer more to AORT or TMCI?

In the previous week, Artivion had 3 more articles in the media than Treace Medical Concepts. MarketBeat recorded 4 mentions for Artivion and 1 mentions for Treace Medical Concepts. Artivion's average media sentiment score of 0.87 beat Treace Medical Concepts' score of 0.59 indicating that Artivion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TNDM or TMCI?

In the previous week, Tandem Diabetes Care had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for Tandem Diabetes Care and 1 mentions for Treace Medical Concepts. Tandem Diabetes Care's average media sentiment score of 0.90 beat Treace Medical Concepts' score of 0.59 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TMCI or CNMD?

In the previous week, CONMED had 4 more articles in the media than Treace Medical Concepts. MarketBeat recorded 5 mentions for CONMED and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat CONMED's score of 0.28 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer TMCI or DRTS?

In the previous week, Alpha Tau Medical had 6 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Alpha Tau Medical and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat Alpha Tau Medical's score of -0.06 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Tau Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Treace Medical Concepts (TMCI) Competitors

$4.21 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$4.20 -0.01 (-0.24%)

As of 07/2/2026 05:39 PM Eastern

Compare

TMCI vs. AORT, TNDM, CNMD, DRTS, and AVR

Should you buy Treace Medical Concepts stock or one of its competitors? MarketBeat compares Treace Medical Concepts with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Treace Medical Concepts include Artivion (AORT), Tandem Diabetes Care (TNDM), CONMED (CNMD), Alpha Tau Medical (DRTS), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry.

How does Treace Medical Concepts compare to Artivion?

Artivion (NYSE:AORT) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

86.4% of Artivion shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 6.3% of Artivion shares are owned by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Artivion currently has a consensus target price of $44.17, indicating a potential upside of 84.72%. Treace Medical Concepts has a consensus target price of $4.77, indicating a potential upside of 13.30%. Given Artivion's stronger consensus rating and higher possible upside, analysts plainly believe Artivion is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Artivion has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.63	$9.77M	$0.24	99.63
Treace Medical Concepts	$212.69M	1.28	-$59M	-$0.97	N/A

Artivion has a net margin of 2.55% compared to Treace Medical Concepts' net margin of -29.44%. Artivion's return on equity of 7.15% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

In the previous week, Artivion had 3 more articles in the media than Treace Medical Concepts. MarketBeat recorded 4 mentions for Artivion and 1 mentions for Treace Medical Concepts. Artivion's average media sentiment score of 0.87 beat Treace Medical Concepts' score of 0.59 indicating that Artivion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Artivion has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

Summary

Artivion beats Treace Medical Concepts on 14 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to Tandem Diabetes Care?

Tandem Diabetes Care (NASDAQ:TNDM) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Treace Medical Concepts has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tandem Diabetes Care	$1.01B	1.03	-$204.71M	-$1.40	N/A
Treace Medical Concepts	$212.69M	1.28	-$59M	-$0.97	N/A

84.1% of Treace Medical Concepts shares are owned by institutional investors. 2.1% of Tandem Diabetes Care shares are owned by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Tandem Diabetes Care has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market.

Tandem Diabetes Care has a net margin of -9.20% compared to Treace Medical Concepts' net margin of -29.44%. Tandem Diabetes Care's return on equity of -53.88% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

In the previous week, Tandem Diabetes Care had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for Tandem Diabetes Care and 1 mentions for Treace Medical Concepts. Tandem Diabetes Care's average media sentiment score of 0.90 beat Treace Medical Concepts' score of 0.59 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tandem Diabetes Care	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tandem Diabetes Care presently has a consensus price target of $29.13, indicating a potential upside of 90.11%. Treace Medical Concepts has a consensus price target of $4.77, indicating a potential upside of 13.30%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, research analysts clearly believe Tandem Diabetes Care is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.45
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Tandem Diabetes Care beats Treace Medical Concepts on 11 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to CONMED?

Treace Medical Concepts (NASDAQ:TMCI) and CONMED (NYSE:CNMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

CONMED has a net margin of 4.00% compared to Treace Medical Concepts' net margin of -29.44%. CONMED's return on equity of 13.84% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
CONMED	4.00%	13.84%	6.05%

In the previous week, CONMED had 4 more articles in the media than Treace Medical Concepts. MarketBeat recorded 5 mentions for CONMED and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat CONMED's score of 0.28 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treace Medical Concepts has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, CONMED has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market.

Treace Medical Concepts currently has a consensus price target of $4.77, suggesting a potential upside of 13.30%. CONMED has a consensus price target of $39.50, suggesting a potential upside of 16.88%. Given CONMED's higher probable upside, analysts plainly believe CONMED is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
CONMED	2 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.71

CONMED has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.28	-$59M	-$0.97	N/A
CONMED	$1.37B	0.74	$47.06M	$1.77	19.09

84.1% of Treace Medical Concepts shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

CONMED beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to Alpha Tau Medical?

Treace Medical Concepts (NASDAQ:TMCI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Treace Medical Concepts has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

Alpha Tau Medical has lower revenue, but higher earnings than Treace Medical Concepts. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.28	-$59M	-$0.97	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 6 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Alpha Tau Medical and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat Alpha Tau Medical's score of -0.06 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Tau Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Tau Medical has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -29.44%. Treace Medical Concepts' return on equity of -67.04% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Alpha Tau Medical	N/A	-73.23%	-52.90%

Treace Medical Concepts presently has a consensus target price of $4.77, suggesting a potential upside of 13.30%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential downside of 4.76%. Given Treace Medical Concepts' higher probable upside, equities analysts plainly believe Treace Medical Concepts is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29

Summary

Treace Medical Concepts beats Alpha Tau Medical on 8 of the 15 factors compared between the two stocks.

How does Treace Medical Concepts compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

84.1% of Treace Medical Concepts shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Anteris Technologies Global has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

In the previous week, Anteris Technologies Global had 4 more articles in the media than Treace Medical Concepts. MarketBeat recorded 5 mentions for Anteris Technologies Global and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat Anteris Technologies Global's score of 0.38 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treace Medical Concepts has a net margin of -29.44% compared to Anteris Technologies Global's net margin of -5,148.78%. Treace Medical Concepts' return on equity of -67.04% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

Treace Medical Concepts has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	521.86	-$94.14M	-$2.23	N/A
Treace Medical Concepts	$212.69M	1.28	-$59M	-$0.97	N/A

Anteris Technologies Global currently has a consensus target price of $16.00, suggesting a potential upside of 56.25%. Treace Medical Concepts has a consensus target price of $4.77, suggesting a potential upside of 13.30%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Treace Medical Concepts beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMCI vs. The Competition

Export

Metric	Treace Medical Concepts	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$273.12M	$7.57B	$7.16B	$12.48B
Dividend Yield	N/A	1.32%	2.66%	6.52%
P/E Ratio	-4.34	52.12	28.02	24.70
Price / Sales	1.28	49.46	540.37	99.49
Price / Cash	N/A	26.72	49.26	57.09
Price / Book	3.07	7.48	10.96	6.46
Net Income	-$59M	$159.19M	$3.57B	$337.01M
7 Day Performance	-5.61%	-0.39%	2.12%	1.69%
1 Month Performance	19.94%	-0.43%	5.25%	3.81%
1 Year Performance	-30.42%	3.14%	33.29%	23.90%

Treace Medical Concepts Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMCI Treace Medical Concepts	2.1858 of 5 stars	$4.21 flat	$4.77 +13.3%	-30.4%	$273.12M	$212.69M	N/A	250	Positive News
AORT Artivion	4.5591 of 5 stars	$22.53 +0.6%	$44.17 +96.0%	-22.2%	$1.09B	$441.33M	93.88	1,800
TNDM Tandem Diabetes Care	3.2848 of 5 stars	$15.09 -4.7%	$29.13 +93.0%	-10.2%	$1.08B	$1.01B	N/A	2,500	Positive News
CNMD CONMED	3.7048 of 5 stars	$32.68 -5.0%	$39.50 +20.9%	-37.8%	$1.04B	$1.37B	18.46	3,900	News Coverage
DRTS Alpha Tau Medical	1.5033 of 5 stars	$12.58 +12.1%	$12.60 +0.2%	+317.4%	$1.01B	N/A	N/A	80	News Coverage Analyst Downgrade Insider Trade Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMCI) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Competitors

TMCI vs. AORT, TNDM, CNMD, DRTS, and AVR

How does Treace Medical Concepts compare to Artivion?

Summary

How does Treace Medical Concepts compare to Tandem Diabetes Care?

Summary

How does Treace Medical Concepts compare to CONMED?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Summary

How does Treace Medical Concepts compare to Anteris Technologies Global?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Treace Medical Concepts (TMCI) Competitors

TMCI vs. AORT, TNDM, CNMD, DRTS, and AVR

How does Treace Medical Concepts compare to Artivion?

Do institutionals and insiders have more ownership in AORT or TMCI?

Do analysts rate AORT or TMCI?

Which has stronger valuation and earnings, AORT or TMCI?

Is AORT or TMCI more profitable?

Does the media refer more to AORT or TMCI?

Which has more volatility & risk, AORT or TMCI?

Summary

How does Treace Medical Concepts compare to Tandem Diabetes Care?

Which has preferable valuation & earnings, TNDM or TMCI?

Do institutionals & insiders believe in TNDM or TMCI?

Which has more volatility & risk, TNDM or TMCI?

Is TNDM or TMCI more profitable?

Does the media prefer TNDM or TMCI?

Do analysts prefer TNDM or TMCI?

Summary

How does Treace Medical Concepts compare to CONMED?

Is TMCI or CNMD more profitable?

Does the media favor TMCI or CNMD?

Which has more volatility & risk, TMCI or CNMD?

Do analysts recommend TMCI or CNMD?

Which has better valuation and earnings, TMCI or CNMD?

Do insiders and institutionals hold more shares of TMCI or CNMD?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Which has more risk & volatility, TMCI or DRTS?

Which has higher earnings and valuation, TMCI or DRTS?

Do institutionals & insiders have more ownership in TMCI or DRTS?

Does the media prefer TMCI or DRTS?

Is TMCI or DRTS more profitable?

Do analysts prefer TMCI or DRTS?

Summary

How does Treace Medical Concepts compare to Anteris Technologies Global?

Do insiders and institutionals hold more shares of AVR or TMCI?

Which has more volatility and risk, AVR or TMCI?

Does the media refer more to AVR or TMCI?

Is AVR or TMCI more profitable?

Which has higher valuation & earnings, AVR or TMCI?

Do analysts rate AVR or TMCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools